Phase 2 Parkinson's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged between 30 and 80 years old (inclusive).
- People who have been diagnosed with Parkinson's disease of unknown cause (idiopathic PD), based on a specific set of diagnostic guidelines, within the last 3 years.
- People whose Parkinson's disease is at a mild to moderate stage (Hoehn and Yahr stages 1–3) and who are currently receiving treatment for it.
- People who are experiencing sleep problems, as measured by a score above 5 on a standard sleep quality questionnaire called the Pittsburgh Sleep Quality Index (PSQI).
- People who have signed a consent form that has been reviewed and approved by an ethics board.
- People whose Parkinson's disease medications have not changed in the four weeks before joining the trial, and who are able to keep those medications unchanged throughout the study.
- People who take other medications that may affect sleep (except those specifically not allowed) are eligible, provided the dose has been stable for at least four weeks before screening and stays the same during the study.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have an allergy to menthol.
- People who are pregnant or breastfeeding.
- People diagnosed with a form of Parkinson's disease that is caused by another condition (secondary PD) or an atypical Parkinson's-like condition.
- People who have certain serious health conditions, including kidney failure (uremia), severe liver scarring (cirrhosis), heart failure with fluid in the lungs, blood clotting disorders, epilepsy, alcohol dependency, or drug misuse (confirm with trial site for the full list).
- People considered unsuitable for the trial by the lead researcher overseeing the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yi-Hung Chen, PhD, International Master Program in Integrative Health, College of Chinese Medicine, China Medical University
Phone: (886)02-27372181
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Unified Parkinson's Disease Rating Scale (UPDRS) I,II,III; Unified Parkinson's Disease Rating Scale (UPDRS) I,II,III; Unified Parkinson's Disease Rating Scale (UPDRS) I,II,III; Pittsburgh Sleep Quality Index (PSQI); Pittsburgh Sleep Quality Index (PSQI); Pittsburgh Sleep Quality Index (PSQI)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.